Marta.jpg

marta rychert, BA, LLM, PhD

Marta is a Research Officer at the SHORE & Whariki Research Centre. Her work lies at the intersection of health, policy and law, with particular focus on the legal aspects of regulating AOD (alcohol and other drugs). This includes new policy responses to recreational cannabis, medicinal cannabis law reform, regulatory approaches to new psychoactive substances (NPS, “legal highs”) and regulation of other psychoactive products such as alcohol, tobacco and e-cigarettes.  

Her PhD critically analysed New Zealand’s Psychoactive Substances Act 2013 and its implementation process. She currently leads a Marsden project investigating international not-for-profit approaches to cannabis law reform (2019-2022) and Health Research Council funded study on medicinal cannabis law reform in New Zealand (2019-2022). Prior to joining SHORE, she worked at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon, where she analysed the drug policies of European Union countries. As well as a PhD in Public Health (Massey University, New Zealand), she holds a Master’s Degree in Law (University of Warsaw, Poland).

Email: m.rychert@massey.ac.nz


Journal articles

Rychert, M. & Wilkins, C. (2019). A 'community enterprise' model for recreational cannabis: Lessons from alcohol licensing trusts in New Zealand. International Journal of Drug Policy, 67, 72-78.

Rychert, M., & Wilkins, C. (2019). New Zealand’s review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum? [Letter]. Addiction, 114(6), 1129-1130.

Rychert, M. & Diesfeld, K. (2019). Teachers’ health, wellbeing and professional misconduct. An exploratory analysis of cases from New Zealand’s Teachers Disciplinary Tribunal. Journal of Law and Medicine, 26, 922-942.

Surgenor, L., Diesfeld, K. & Rychert, M. (2019). Consensual sexual relationships between health practitioners and their patients: An analysis of disciplinary cases from New Zealand. Psychiatry, Psychology and Law. In press.

Wilkins, C., Rychert, M., Romeo, J., Randerson, S. (2019). Smoke in our eyes: the Sense Partners’ evaluation of the legalisation of cannabis in New Zealand. New Zealand Medical Journal, 132 (1490), 6-9.

Wilkins, C., Romeo, J., Rychert, M., Prasad, J., & Graydon-Guy, T. (2018). Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis? International Journal of Drug Policy, 61, 15-22.

Rychert, M., & Wilkins, C. (2018). Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory. Addiction, 113(11), 2132-2139. Doi: 10.1111/add.14260.

Wilkins, C., & Rychert, M. (2018). Responding to a new wave of high potency synthetic cannabinoids [Editorial]. New Zealand Medical Journal, 131(1481), 6-8. A449

Moore, J., Forster, C, Diesfeld, K & Rychert, M. (2018). New Zealand Lawyers and Conveyancers Disciplinary Tribunal cases involving vulnerable clients, 2011-2017 International Journal of the Legal Profession. Doi: 10.1080/09695958.2018.1543119.

Rychert, M. (2018). New Zealand court dismisses Ministry of Health case against ‘heat-not-burn’ tobacco products, highlighting the need to future-proof tobacco control laws. [Letter] Addiction, 113, 1951-54. Doi: https://doi.org/10.1111/add.14376

Rychert, M., & Wilkins, C. (2018). A critical analysis of the implementation of a legal regulated market for new psychoactive substances (“legal highs”) in New Zealand. International Journal of Drug Policy, 55, 88-94

Rychert, M., Wilkins, C., Parker, K., & Witten, K. (2018). Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand. Drug and Alcohol Review, 37(3), 406-413.

Rychert, M., Wilkins, C., & Witten, K. (2018). “Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand, Drugs: Education, Prevention & Policy, 25(3), 254-261.

Rychert, M. (2017). New Zealand’s legal action against IQOS postponed, consultation with Big Tobacco follows. New Zealand Medical Journal, 130(1465), 109-111.

Rychert, M., Wilkins, C. & Witten, K. (2017). Issues with monitoring the safety of  psychoactive products under a legal regulated market for new psychoactive substances (NPS) (‘legal highs’) in New Zealand. Drug and Alcohol Review, 36(5), 589-596.

Wilkins, C., & Rychert, M. (2017). Recent developments with the New Zealand regulated market approach to 'low risk' psychoactive products. Addiction, 112(1), 34-36.

Rychert, M., & Wilkins, C. (2017), Thirty-one psychoactive plants exempted from New Zealand’s Psychoactive Substances Act 2013 [Letter] Addiction, 112(1), 181-182.

Rychert, M., & Wilkins, C. (2016), Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand. International Journal of Drug Policy, 37, 90-97.

Rychert, M., & Wilkins, C. (2016). What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties. Drug Testing and Analysis, 8(8), 768–778.

Wilkins, C., Prasad, J., Wong, K.C., Graydon-Guy, T., & Rychert, M. (2016).  An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland. New Zealand Medical Journal, 129 (1431), 51-58.

Rychert, M., & Wilkins, C. (2016). The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution. International Journal of Drug Policy, 26, 1273-1278.

Rychert, M., & Wilkins, C. (2016), Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for ‘low-risk’ psychoactive products in New Zealand? [Letter] Addiction 110(4), 714-715.

Rychert, M., & Wilkins, C. (2015). Did we have the wrong debate about Elixinol™ and medicinal cannabis? [Letter] New Zealand Medical Journal, 128(1421), 69-70.

Peer reviewed book chapters

Wilkins, C., Rychert, M., Byrska, B., Van Hout, M., Corazza, O., & Roman-Urrestarazu, A. (2017). Exploring Innovative Policy Responses to NPS and ‘Legal Highs’ in New Zealand, Poland, Republic of Ireland and the UK. In O. Corazza & A. Roman-Urrestarazu (Eds.), Novel Psychoactive Substances: Policy, Economics and Drug Regulation (pp. 57-68). Switzerland: Springer Nature.

Wilkins, C., Prasad, J., Parker, K., Rychert, M., & Barnes, H. M. (2017). Recent Trends in Alcohol and Other Drug Use Among Police Detainees in New Zealand, 2010–2015. In S. Nielsen, R. Bruno, & S. Schenk (Eds.), Non-medical and illicit use of psychoactive drugs (pp. 161-172). Cham: Springer International Publishing.

Rychert, M., & Wilkins, C. (2017), New Zealand’s pre-market approval regime for ‘low risk’ new psychoactive substances (NPS, ‘legal highs’) - a regulatory alternative to prohibition. In A. Malczewski (Ed.) Monitoring and response to Drugs, Drug Addiction and New Psychoactive Substances (pp. 171-182). Poland: Information Centre for Drugs and Drug Addiction. (Published in English and Polish)

Reports

Randerson, S., Casswell, S., & Rychert, M. (2019). Diminished inclusivity in public space: An important aspect of alcohol’s harm to others. A report for the Health Promotion Agency. Auckland: SHORE & Whariki Research Centre, Massey University.

Rychert, M., Wilkins, C., Romeo, J.S. & T. Graydon-Guy (2019). Could the community alcohol licensing trust model be applied to regulate legal cannabis? Research Bulletin. Auckland: SHORE & Whariki Research Centre, Massey University.

Wilkins, C., Rychert, M. & J.S. Romeo (2019). Utilising an online survey to monitor availability, prices, and involvement of organised crime in supply of methamphetamine in New Zealand. A report for the European Union Drugs Agency (EMCDDA). Auckland: SHORE & Whariki Research Centre, Massey University.

Wilkins, C. Prasad, J., Rychert, M. Romeo, J.S. & T. Graydon-Guy (2018). Which regions reported higher levels of methamphetamine and cannabis dependency and need for help with substance use problems? Research Bulletin. Auckland: SHORE & Whariki Research Centre, Massey University.

Wilkins, C., Prasad, J., Parker, K., Moewaka Barnes, H., Asiasiga, L., & Rychert, M. (2017). New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) 2010–2016. Auckland: SHORE & Whariki Research Centre, Massey University.

Wilkins, C., Prasad, J., Parker, K., Moewaka-Barnes, H., Romeo, J.S., & Rychert, M. (2017), New Zealand Arrestee Drug Use Monitoring (NZ-ADUM): 2016 Report. SHORE & Whāriki Research Centre, Massey University, Auckland.

Wilkins, C., Prasad, J., Romeo, J. S., & Rychert, M. (2017). Recent trends in illegal drug use in New Zealand, 2006-2016: Findings from the Illicit Drug Monitoring System. December. Auckland: Social and Health Outcomes Research and Evaluation (SHORE), College of Health, Massey University.

Wilkins, C., Prasad, J., Wong, K., & Rychert, M. (2017), Recent trends in illegal drug use in New Zealand 2006-2015: Findings from the Illegal Drug Monitoring System (IDMS). SHORE & Whāriki Research Centre, Massey University, Auckland.

Wilkins, C., Prasad, J., Parker, K., Rychert, M., & Moewaka Barnes, H. (2016). New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) 2010 - 2015. Auckland: SHORE & Whariki Research Centre, College of Health, Massey University.

Wilkins, C. & M. Rychert (2015) The history, development and implementation of the pre-market regulated legal regime for ‘low risk’ psychoactive products (‘legal highs’) in New Zealand. A report for the European Union Drugs Agency (EMCDDA). Auckland: SHORE & Whariki Research Centre, Massey University.

Wilkins, C., Prasad, J., Parker, K., Moewaka Barnes, H., Asiasiga, L., & Rychert, M. (2015). New Zealand Arrestee Drug Use Monitoring (NZ-ADUM) 2010 - 2014. Auckland: SHORE & Whariki Research Centre, College of Health, Massey University.

Wilkins, C., Prasad, J., Wong, K., & Rychert, M. (2015), Recent trends in illegal drug use in New Zealand 2006-2014: Findings from the Illegal Drug Monitoring System (IDMS). SHORE & Whāriki Research Centre, Massey University, Auckland.

Wilkins, C., Prasad, J., Wong, K., & Rychert, M. (2014). Recent trends in illegal drug use in New Zealand 2006-2013: Findings from the 2006, 2007, 2008, 2009, 2010, 2011, 2012 and 2013 Illicit Drug Monitoring System (IDMS). Auckland: SHORE & Whariki Research Centre, Massey University.

Rychert, M., Palczak, K., Zobel, F. & Hughes, B. (2014), Drug Policy Profile: Poland. EU Drugs Agency (EMCDDA). Publications Office of the European Union, Luxembourg.

Mounteney, J., Groshkova, T., Thanki, D., Cunningham, A. & Rychert, M. (2014), Discovering Methamphetamine trends in Europe, EMCDDA Papers, Publications Office of the European Union, Luxembourg.